English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
Article details
13 December 2013 - Helsinn.com

Helsinn and Italfarmaco reinforce their alliance through the grant of rights to phase-III ghrelin receptor agonist Anamorelin in Italy